SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001457612-18-000069
Filing Date
2018-06-25
Accepted
2018-06-25 20:07:58
Documents
1
Period of Report
2018-06-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_152997166026024.html 4  
1 FORM 4 wf-form4_152997166026024.xml 4 3860
  Complete submission text file 0001457612-18-000069.txt   5310
Mailing Address C/O MILLENNIUM PHARMACEUTICALS INC 40 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address
BATE KENNETH (Reporting) CIK: 0001210238 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36289 | Film No.: 18918091

Mailing Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140 617-876-8191
GENOCEA BIOSCIENCES, INC. (Issuer) CIK: 0001457612 (see all company filings)

IRS No.: 510596811 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)